Award
Delivery Order #SPE2DR26F0F0Y
AmerisourceBergen Drug Corp Awarded Delivery Order for Nelarabine Vials
Buyer
Defense Logistics Agency
Award Amount
$12,130.86
Ceiling
$12,130.86
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26F0F0Y
NAICS
424210
This delivery order contract was awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor, under an existing indefinite delivery vehicle that supports healthcare supply chains. The contract involves the procurement of Nelarabine 250 mg/50 mL vials, a specialized chemotherapy drug. This award is significant as it ensures the availability of critical cancer treatment medication to healthcare providers, enhancing patient care and public health outcomes. The scope of work covers the delivery of the specified pharmaceutical product to a designated location in Pennsylvania for a short-term period. The order was awarded through the established contract vehicle, likely leveraging prior performance and competitive selection from the parent indefinite delivery contract. The timeline reflects a brief procurement window, with performance expected within a single day, emphasizing the capability for rapid fulfillment within ongoing pharmaceutical supply efforts.
Description
4571020201!NELARABINE 250 MG/50 ML VIAL 50ML